We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Events

25 Jul 2025 - 27 Jul 2025

High-Resolution ECG Helps Diagnose Heart Attacks

By HospiMedica International staff writers
Posted on 17 Nov 2014
Innovative technology permits clinicians to closely observe the QRS complex of an electrocardiogram (ECG), which holds clues on the patient’s cardiac condition.

The HyperQ High-Res AD-100 ECG system is an add-on, dual mode device that is based upon the functionalities of protocols using standard 12-lead stress ECG systems, while adding an enhanced ECG analysis that involves the acquisition of ECG signals at high frequencies, on top of standard ECG parameters that are read at low frequencies. More...
Using HyperQ technology also prevents unnecessary exposure to radioactive or invasive procedures in patients that are inherent in other advanced ischemic heart disease (IHD) diagnosis systems.

A meticulous, intuitive user interface, together with state-of-the-art signal processing algorithms and comprehensive reports, provide a high-quality stress system with significantly enhanced diagnostic accuracy and levels of sensitivity and specificity, similar to those of radioactive procedures. And while stress test accuracy in women is notoriously low, the HyperQ diagnosis performs equally well in both sexes, adding enhanced diagnosis in women. The HyperQ High-Res AD-100 ECG system is a development of Biological Signal Processing (BSP; Tel Aviv, Israel), and has been approved by the US Food and Drug Administration (FDA).

“The HyperQ system can be used during standard exercise stress testing and stress echocardiography, and features such as connectivity to automatic blood pressure measuring devices enhance the system’s functionality. The user-interface is intuitive and friendly,” said Jared Widell, MD, director of the stress echocardiography laboratory at Washington Hospital Center (Washington DC, USA).

The physiological significance of the high frequency components of the QRS complex was first described in the 1980’s. Since then, it has been extensively researched and clinically validated as an important diagnostic tool.

Related Links:

Biological Signal Processing



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
12-Channel ECG
CM1200B
New
3-Channel ECG Event Recorder
ECG Time S
New
Measuring Rod
seca 233
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The milli-spinner can shrink blood clots without rupturing them (Photo courtesy of Andrew Brodhead/Stanford)

New Technology More Than Doubles Success Rate for Blood Clot Removal

In cases of ischemic stroke, where a blood clot obstructs oxygen supply to the brain, time is critical. The faster the clot is removed and blood flow restored, the more brain tissue can be saved, improving... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.